• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
    • News & Updates
  • Donate
Home / Patient Corner / Drug Information Sheets / Certolizumab (Cimzia®) Drug Information Sheet

Certolizumab (Cimzia®) Drug Information Sheet

What is Certolizumab (Cimzia®)?

Certolizumab pegol is a drug that reduces the signs and symptoms of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis, and Crohn’s disease. It works to improve such symptoms as joint swelling, pain, fatigue, and morning stiffness. The brand name of certolizumab pegol is Cimzia®. It is a biologic drug that is in a class of drugs called anti-TNFs or TNF blockers.

How do I take it?      

Certolizumab comes in a prefilled syringe (needle). You should be instructed on how to give yourself injections by a healthcare professional.  Each syringe holds 200 mg of medication.

When you start certolizumab, you will receive two 200-mg injections on the first day (week 0), then at 2 weeks and at 4 weeks.  After that first initial dosing, your maintenance dose will be one shot every 2 weeks or 2 shots every 4 weeks.

What about side effects?

The most common side effect is serious infection. Certolizumab can lower the body’s ability to fight infection.  Be sure to contact your physician if you have any signs of infection, such as fever, cough, or red or painful skin. You may have to stop certolizumab while being treated for an infection. You may also have to stop certolizumab if you are planning a surgery.

You will need to have a negative tuberculosis (TB) skin test before beginning certolizumab therapy.  Your doctor may also want to check your blood to make sure you do not have Hepatitis B or C.

You should not be given any live vaccines, such as Flu-Mist (the nasal-spray flu vaccine), the chicken pox vaccine, the shingles vaccine or the measles vaccines, while on certolizumab. The flu-shot (flu injection vaccine) is not a live virus and all patients should consider having this vaccination yearly.

Occasionally some patients develop a reaction at the injection site such as, redness, pain or swelling.  Notify your doctor to find out the best way to handle any reactions.

Make sure your doctor knows if you have any symptoms of heart disease, like shortness of breath when you lie down or exert yourself, swelling or edema of your legs, ankles, and feet, or chest pain or heaviness. This class of drugs may cause your heart disease to get worse.

Tell your doctor if you live or have lived in an area where fungal infections are more common. You may be at higher risk of getting a fungal infection while taking certolizumab

If you have Multiple Sclerosis, this is not the right medicine for you. This class of drugs can make Multiple Sclerosis worse.

Allergic reactions may happen. Call your healthcare provider or an emergency medical provider if you have any signs of an allergic reaction, such as rashes or hives; swollen face, eyelids, lips, or tongue; and difficulty breathing.

What about other medications?

When you are taking certolizumab, it is very important that your doctors know if you are taking any other medicine. This includes prescription and non-prescription medicines as well as birth control pills, vitamins, and herbal supplements.  Certolizumab can be taken with other medications – NSAIDS (Celebrex, ibuprofen, naproxen), prednisone, methotrexate, and plaquenil. You should not take certolizumab with other TNF-blockers, or other biologic drugs used to treat RA.

What else should I know?

This medication must be refrigerated.  Do not freeze this medicine.

You must continue your regular visits to the rheumatologist. Your doctor will monitor you for any improvements in your disease and for any signs of infections. Most patients notice an improvement in symptoms after the first or second injection.

A Federal Drug Administration approved medication guide can be found at:

  • http://www.cimzia.com/assets/pdf/MedicationGuide.pdf
Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Use of this Site

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Drug Information

  • Drug Information Sheets
  • How to Give a Subcutaneous Injection

List of Treatments

  • Abatacept (Orencia®)
  • Adalimumab (Humira®)
  • Alendronate (Fosamax®)
  • Anakinra (Kineret®)
  • Apremilast (Otezla®)
  • Azathioprine (Imuran®)
  • Certolizumab (Cimzia®)
  • Corticosteroids (i.e. Prednisone)
  • Etanercept (Enbrel®)
  • Febuxostat (Uloric®)
  • Golimumab (Simponi®)
  • Golimumab for infusion (Simponi Aria®)
  • Hyaluronate (Synvisc® & Hyalgan®)
  • Hydroxychloroquine (Plaquenil®)
  • Ibandronate Sodium (Boniva®)
  • Infliximab (Remicade®)
  • Leflunomide (Arava®)
  • Lesinurad/Allopurinol (Duzallo®)
  • Lesinurad (Zurampic®)
  • Methotrexate (Oral)
  • Methotrexate (Injection)
  • Non-Steroidal Anti-inflammatory Drugs
  • Pegloticase (KRYSTEXXA®)
  • Probenecid
  • Risedronate (Actonel®)
  • Rituximab (Rituxan®)
  • Sarilumab (Kevzara®)
  • Secukinumab (Cosentyx®)
  • Sulfasalazine (Azulfidine®)
  • Teriparatide (Forteo®)
  • Tocilizumab (Actemra®)
  • Tofacitinib (Xeljanz®/XeljanzXR®)
  • Ustekinumab (Stelara®) Drug Information Sheet
  • Zolendronic Acid (Reclast®)
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2025 Johns Hopkins Arthritis Center
Patient Privacy